Hyperliquid Strategies Inc is a digital asset treasury company. The Company is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.
Back to dashboard
Company Information
About this company
Key people
Bob Diamond
Chairman of the Board
David Ira Schamis
Chief Executive Officer, Director
Brett Beldner
Chief Financial Officer, Secretary
Jeroen Nieuwkoop
Chief Operating Officer
Jeff Tuder
Director
Nailesh Bhatt
Independent Director
Albert D. Dyrness
Independent Director
Thomas C. King
Independent Director
Click to see more
Key facts
- Shares in issue281.34m
- EPICPURR
- ISINUS44916Y1064
- LocationUnited States
- SectorTechnology
- IndustryComputer Services
- Market cap$2.52bn
- Employees-
- ExchangeNASDAQ
- IndexTR Equity United States Index
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.